WU NK 201
Alternative Names: WU-NK-201Latest Information Update: 17 Sep 2021
At a glance
- Originator WUGEN
- Class Antineoplastics; Immunotherapies; NKT cell therapies
- Mechanism of Action Immunologic cytotoxicity; Natural Killer T-cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Solid tumours